Watch Demo

Latvia Analgesic Industry Outlook 2022 - 2026

See how Latvia Analgesic performed compared to key markets such as Germany, Spain and Canada.

Key Market Indicators

Latvian analgesic medicine sales are expected to hit $14.1 million by 2026. In 2021, the market was valued at $13 million, a 1.9% year-on-year increase. Since 2006, sales have grown at an average rate of 7.9% annually. Latvia was 21st in the global ranking of analgesic medicine sales in 2021, behind Hungary at $13 million. Spain, Canada and Italy were the top three countries in the ranking.

Marketing Banner

Latvia Analgesic Market Data and Forecasts

How much will Latvia Analgesic Market grow to 2026?

Forecast: Analgesic Medicine Sales in Latvia
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Latvia
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Latvia
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Use in Latvia
More in Analgesic Industry for 2028

Improve your Knowledge with the latest Indicators and Trends